Praxiom Health

Medications offered

As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.

• Compounded semaglutideCompounded · not FDA-approved
• Compounded tirzepatideCompounded · not FDA-approved
• Brand-name GLP-1 medication (oversight only)FDA-approved

What they publish

Praxiom Health publishes 7 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers

Membership / programme fee

For the brand-name route, published at $74.99/month for ongoing physician oversight and prescription support, with the medication bought separately. A one-time $74.99 fee is published for filing a prior authorisation. For the compounded route, no separate membership — the monthly package is all-in (as published)

Medication cost

Compounded semaglutide published at $214.99/month and compounded tirzepatide at $263.99/month, each stated to include monthly clinical oversight, the medication, discreet shipping and pharmacy coordination. States there are no multi-month plans or discounts and that billing is monthly when treatment is prescribed (as published)

Introductory offer

Not publicly disclosed on the pages we captured.

Insurance

States it does not bill insurance or handle claims, but will submit a prior authorisation for a brand-name medication on your behalf for a one-time $74.99 fee, with coverage and out-of-pocket cost then determined by your plan and pharmacy.

HSA / FSA

Not publicly disclosed on the pages we captured.

Consultation process

Secure eligibility form taking two to five minutes with no payment required to begin, then a physician review. States monthly physician review is included and is completed through the secure portal, with live calls scheduled only when clinically needed.

Eligibility

States it is unavailable in Arkansas, California, Idaho, Mississippi and West Virginia. Clinical criteria such as a BMI threshold were not published on the pages we captured.

Lab work

Not publicly disclosed on the pages we captured.

Pharmacy fulfilment

States compounded formulations are sourced from state-licensed US pharmacies when clinically appropriate and permitted. The pharmacies are not named. For the brand-name route, fulfilment is handled directly through the manufacturer or pharmacy.

Shipping

States discreet shipping and pharmacy coordination are included in the monthly package price, with no separate shipping or handling fee.

Support services

States monthly physician review plus nurse support between check-ins, and describes this explicitly as an alternative to 'prescription and disappear' care.

Cancellation

States billing is monthly when treatment is prescribed and that you see pricing before any charge is made. Formal cancellation terms were not published on the pages we captured.

Refunds

Refund terms were not published on the pages we captured.

What stands out

• Prices to the cent — $214.99 and $263.99 — and states there are no multi-month plans or discounts. Declining to offer prepaid multi-month plans removes the discontinuation trap that most of this market builds in.
• Publishes a brand-name pathway priced separately at $74.99/month for oversight only, with the drug bought through the manufacturer. Very few compounded sellers offer a route that does not involve buying their compounded product.
• Publishes a one-time $74.99 prior authorisation fee — a service most cash-pay providers do not offer at all, and one that few of those who do will price openly.
• Names the five states it does not serve: Arkansas, California, Idaho, Mississippi and West Virginia.
• States monthly physician review is included and completed through the portal, with live calls only when clinically needed — so 'physician-led' here means an asynchronous monthly review rather than a scheduled call.
• Displays LegitScript certification.
• States there are no hidden fees for shipping, pharmacy handling or ongoing support.
• No refund policy is published to sit alongside the monthly billing.

Questions to ask before you pay

These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.

• The $74.99 brand-name option covers oversight only. What will the medication itself cost you through the manufacturer channel on top of that?
• The prior authorisation fee is charged whether or not the authorisation succeeds. What happens if your insurer declines?
• Which state-licensed pharmacy compounds your medication?
• No refund policy is published. If you are billed and then decide to stop, what is recoverable?
• What BMI or clinical criteria apply, given none are published?
• Compounded medication is not FDA-approved. Do you understand what that means for oversight and recourse?

Frequently asked